Oslo Cancer Cluster meeting

Cancer Crosslinks 2019

Next Wave Precision Oncology – Connecting the Dots for Improved Patient Care

Photo:

OCC

Main content

Join Cancer Crosslinks 2019

Hear from a distinguished panel of international and Norwegian experts as they discuss the Next Wave of Precision Oncology, share new perspectives, and address the challenges and opportunities ahead.

The Cancer Crosslinks 2019 Program is available HERE

Daytime Program: 9am-4pm at Oslo Cancer Cluster Innovation Park

Program highlights include:

Naiyer Rizvi, Thoracic Oncology and Director of Immunotherapeutics for the Division of Hematology and Oncology, Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center, USA
Aaron Goodman, Moores Cancer Center, Division of Blood and Marrow Transplantation, UC San Diego Health, USA
Randy F. Sweis, Section of Hematology/Oncology, Committee on Clinical Pharmacology and Pharmacogenomics The University of Chicago Medicine & Biological Sciences, USA
Marco Gerlinger, Center for Evolution and Cancer, The Institute of Cancer Research, London and Gastrointestinal Cancer Unit, The Royal Marsden Hospital, UK
Lars Bullinger, Department of Hematology, Oncology and Tumorimmunology, Charité University Medicine Berlin, Germany
James Peach, Precision Medicine Lead, UK Medicines Discovery Catapult, Alderly Park, UK
Kristin Vinje, Vice-Dean Faculty of Natural Sciences, University of Oslo
Ola Myklebost, Dept. of Clinical Science, University of Bergen
Christian Kersten, Senior Consultant, Center for Cancer Treatment, Sørlandet Hospital, Kristiansand
Bjørn Tore Gjertsen, Senior Consultant Hematology, Haukeland University Hospital and Director of Research, Haukeland University Hospital, Helse Bergen Health Trust, and Centre for Cancer Biomarkers CCBIO, University of Bergen
Hege G. Russnes, Senior Consultant and Researcher, Oslo University Hospital

Evening Program: Reception begins at 6:30pm, Hotel Continental, Oslo

Registration and more information is available at this website.

Meeting

17.01.2019 - 08.30–16.00

Kaare Norum Auditorium @ Oslo Cancer Cluster

Add to calendar

CCBIO is an OCC member

Oslo Cancer Cluster (OCC) is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines.

The cluster is a national non-profit member and network organization for Norwegian and international companies, research and financial institutions, university hospitals, and organizations – all working in the field of cancer.

The cluster is continuously expanding its member base. The goal is to become a leading oncology cluster in Europe.

The Network

Oslo Cancer Cluster strives to create an environment that fosters collaboration and innovation among its members and the community.

To encourage and inspire innovation and “meetings of the minds”, the cluster organizes and co-hosts a series of educational programs featuring distinguished international and national experts, presenting recent advances in oncology.

Members are invited to take an active part in this collaboration, as an organizer and/or participant.

16.11.2018